Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21. / Hansen, Morten; Met, Özcan; Larsen, Niels Bent; Rosenkilde, Mette Marie; Andersen, Mads Hald; Svane, Inge Marie; Hjorto, Gertrud Malene.

I: Cytotherapy, Bind 18, Nr. 9, 09.2016, s. 1187-1196.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Hansen, M, Met, Ö, Larsen, NB, Rosenkilde, MM, Andersen, MH, Svane, IM & Hjorto, GM 2016, 'Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21', Cytotherapy, bind 18, nr. 9, s. 1187-1196. https://doi.org/10.1016/j.jcyt.2016.06.010

APA

Hansen, M., Met, Ö., Larsen, N. B., Rosenkilde, M. M., Andersen, M. H., Svane, I. M., & Hjorto, G. M. (2016). Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21. Cytotherapy, 18(9), 1187-1196. https://doi.org/10.1016/j.jcyt.2016.06.010

Vancouver

Hansen M, Met Ö, Larsen NB, Rosenkilde MM, Andersen MH, Svane IM o.a. Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21. Cytotherapy. 2016 sep.;18(9):1187-1196. https://doi.org/10.1016/j.jcyt.2016.06.010

Author

Hansen, Morten ; Met, Özcan ; Larsen, Niels Bent ; Rosenkilde, Mette Marie ; Andersen, Mads Hald ; Svane, Inge Marie ; Hjorto, Gertrud Malene. / Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21. I: Cytotherapy. 2016 ; Bind 18, Nr. 9. s. 1187-1196.

Bibtex

@article{99171fa5595b4492a8e5590f27339e3d,
title = "Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21",
abstract = "Maturation of dendritic cells (DCs) induces their homing from peripheral to lymphatic tissues guided by CCL21. However, in vitro matured human monocyte-derived DC cancer vaccines injected intradermally migrate poorly to lymph nodes (LNs). In vitro maturation protocols generate DCs with high (type 1 DCs) or low (prostaglandin E2 [PGE2]-DCs) autocrine CCL19 levels, which may potentially interfere with LN homing of DCs. Methods. Employing a three-dimensional (3D) chemotaxis assay, chemokine competition/desensitization studies and short interfering RNA (siRNA) against CCL19, we analyzed the effect of autocrine CCL19 on in vitro migration of human DCs toward CCL21. Results. Using human monocyte-derived DCs in a 3D chemotaxis assay, we are the first to demonstrate that CCL19 more potently induces directed migration of human DCs compared with CCL21. When comparing migration of type 1 DCs and PGE2-DCs, migration of type 1 DCs was strikingly impaired compared with PGE2-DCs, but only toward low concentrations of CCL21. When type 1 DCs were cultured overnight in fresh culture medium (reducing autocrine CCL19 levels), a rescuing effect was observed on migration toward low concentrations of CCL21 in a 3D chemotaxis assay. Finally pre-incubation with CCL19 negatively affected PGE2-DC migration, whereas silencing of CCL19 by siRNA improved type 1 DC migration. Importantly, in both cases, the effect was observed only at low concentrations of CCL21. Conclusions. Our results demonstrate that autocrine CCL19 negatively affects DC migratory potential toward CCL21, the potency difference between CCL19 and CCL21 being the underlying cause. CCL19 secretion level of in vitro matured DCs is an important indicator of DC vaccine homing potential.",
keywords = "Chemotaxis, CCL19, CCL21, dendritic cells, maturation",
author = "Morten Hansen and {\"O}zcan Met and Larsen, {Niels Bent} and Rosenkilde, {Mette Marie} and Andersen, {Mads Hald} and Svane, {Inge Marie} and Hjorto, {Gertrud Malene}",
year = "2016",
month = sep,
doi = "10.1016/j.jcyt.2016.06.010",
language = "English",
volume = "18",
pages = "1187--1196",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Elsevier",
number = "9",

}

RIS

TY - JOUR

T1 - Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21

AU - Hansen, Morten

AU - Met, Özcan

AU - Larsen, Niels Bent

AU - Rosenkilde, Mette Marie

AU - Andersen, Mads Hald

AU - Svane, Inge Marie

AU - Hjorto, Gertrud Malene

PY - 2016/9

Y1 - 2016/9

N2 - Maturation of dendritic cells (DCs) induces their homing from peripheral to lymphatic tissues guided by CCL21. However, in vitro matured human monocyte-derived DC cancer vaccines injected intradermally migrate poorly to lymph nodes (LNs). In vitro maturation protocols generate DCs with high (type 1 DCs) or low (prostaglandin E2 [PGE2]-DCs) autocrine CCL19 levels, which may potentially interfere with LN homing of DCs. Methods. Employing a three-dimensional (3D) chemotaxis assay, chemokine competition/desensitization studies and short interfering RNA (siRNA) against CCL19, we analyzed the effect of autocrine CCL19 on in vitro migration of human DCs toward CCL21. Results. Using human monocyte-derived DCs in a 3D chemotaxis assay, we are the first to demonstrate that CCL19 more potently induces directed migration of human DCs compared with CCL21. When comparing migration of type 1 DCs and PGE2-DCs, migration of type 1 DCs was strikingly impaired compared with PGE2-DCs, but only toward low concentrations of CCL21. When type 1 DCs were cultured overnight in fresh culture medium (reducing autocrine CCL19 levels), a rescuing effect was observed on migration toward low concentrations of CCL21 in a 3D chemotaxis assay. Finally pre-incubation with CCL19 negatively affected PGE2-DC migration, whereas silencing of CCL19 by siRNA improved type 1 DC migration. Importantly, in both cases, the effect was observed only at low concentrations of CCL21. Conclusions. Our results demonstrate that autocrine CCL19 negatively affects DC migratory potential toward CCL21, the potency difference between CCL19 and CCL21 being the underlying cause. CCL19 secretion level of in vitro matured DCs is an important indicator of DC vaccine homing potential.

AB - Maturation of dendritic cells (DCs) induces their homing from peripheral to lymphatic tissues guided by CCL21. However, in vitro matured human monocyte-derived DC cancer vaccines injected intradermally migrate poorly to lymph nodes (LNs). In vitro maturation protocols generate DCs with high (type 1 DCs) or low (prostaglandin E2 [PGE2]-DCs) autocrine CCL19 levels, which may potentially interfere with LN homing of DCs. Methods. Employing a three-dimensional (3D) chemotaxis assay, chemokine competition/desensitization studies and short interfering RNA (siRNA) against CCL19, we analyzed the effect of autocrine CCL19 on in vitro migration of human DCs toward CCL21. Results. Using human monocyte-derived DCs in a 3D chemotaxis assay, we are the first to demonstrate that CCL19 more potently induces directed migration of human DCs compared with CCL21. When comparing migration of type 1 DCs and PGE2-DCs, migration of type 1 DCs was strikingly impaired compared with PGE2-DCs, but only toward low concentrations of CCL21. When type 1 DCs were cultured overnight in fresh culture medium (reducing autocrine CCL19 levels), a rescuing effect was observed on migration toward low concentrations of CCL21 in a 3D chemotaxis assay. Finally pre-incubation with CCL19 negatively affected PGE2-DC migration, whereas silencing of CCL19 by siRNA improved type 1 DC migration. Importantly, in both cases, the effect was observed only at low concentrations of CCL21. Conclusions. Our results demonstrate that autocrine CCL19 negatively affects DC migratory potential toward CCL21, the potency difference between CCL19 and CCL21 being the underlying cause. CCL19 secretion level of in vitro matured DCs is an important indicator of DC vaccine homing potential.

KW - Chemotaxis

KW - CCL19

KW - CCL21

KW - dendritic cells

KW - maturation

U2 - 10.1016/j.jcyt.2016.06.010

DO - 10.1016/j.jcyt.2016.06.010

M3 - Journal article

C2 - 27424146

VL - 18

SP - 1187

EP - 1196

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 9

ER -

ID: 167920292